|
|
Volumn 212, Issue 4, 2000, Pages 139-144
|
|
Treatment of multisystem Langerhans cell histiocytosis. Results of the DAL-HX 83 and DAL-HX 90 studies
a
a
a
a
a
a
|
|
Author keywords
Langerhans cell histiocytosis; Prognosis; Survival; Therapy; Treatment
|
|
Indexed keywords
ETOPOSIDE;
MERCAPTOPURINE;
METHOTREXATE;
PREDNISONE;
VINBLASTINE;
ADOLESCENT;
ARTICLE;
CANCER COMBINATION CHEMOTHERAPY;
CANCER SURVIVAL;
CHILD;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFICACY;
FEMALE;
HISTIOCYTOSIS X;
HUMAN;
INFANT;
MAJOR CLINICAL STUDY;
MALE;
PRESCHOOL CHILD;
SCHOOL CHILD;
TREATMENT OUTCOME;
ADOLESCENT;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CHILD;
CHILD, PRESCHOOL;
DISEASE-FREE SURVIVAL;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FEMALE;
FOLLOW-UP STUDIES;
HISTIOCYTOSIS, LANGERHANS-CELL;
HUMANS;
INFANT;
INFANT, NEWBORN;
MALE;
RANDOMIZED CONTROLLED TRIALS;
RETROSPECTIVE STUDIES;
SURVIVAL ANALYSIS;
TREATMENT OUTCOME;
|
|
EID: 0033847860
PISSN: 03008630
EISSN: None
Source Type: Journal
DOI: 10.1055/s-2000-9667 Document Type: Article |
|
Times cited : (111)
|
|
References (14)
|
